Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
49
|
pubmed:dateCreated |
1979-6-11
|
pubmed:abstractText |
Patients with transitional cell carcinoma of the bladder have a highly significant stepwise decrease in responsiveness to challenge with DNCB with advancing stage of disease. Seventy-five percent of those patients with superficial tumors are skin-test positive versus only 35% for those having tumors that are locally advanced and/or metastatic. MLC response and ability to stimulate in this culture as well as PHA and Con A response of blood leukocytes have been studied in relation to stage of disease and therapy. Recent irradiation appears to inhibit significantly MLC responsiveness, and PHA and Con A blastogenesis. Although responsiveness for this group of patients is decreased from normal, a further decrease occurs in responsiveness to Con A with advancing stage of disease. Blood leukocytes from some patients with urinary bladder carcinoma appear to have a decreased ability to function as stimulator cells in one-way MLC. This ability to stimulate returns to normal levels with tumor removal.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0083-1921
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
111-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:155219-Carcinoma, Transitional Cell,
pubmed-meshheading:155219-Concanavalin A,
pubmed-meshheading:155219-Dinitrochlorobenzene,
pubmed-meshheading:155219-Humans,
pubmed-meshheading:155219-Lymphocyte Activation,
pubmed-meshheading:155219-Lymphocyte Culture Test, Mixed,
pubmed-meshheading:155219-Lymphocytes,
pubmed-meshheading:155219-Male,
pubmed-meshheading:155219-Phytohemagglutinins,
pubmed-meshheading:155219-Skin Tests,
pubmed-meshheading:155219-Urinary Bladder Neoplasms
|
pubmed:year |
1978
|
pubmed:articleTitle |
Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|